ArticleInternational journal of medical sciences2011
Antimicrobial susceptibilities of Brucella isolates from various clinical specimens.
Article in International journal of medical sciences, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 47 citations in OpenAlex.
- A Comprehensive Meta-Analysis on Antimicrobial Resistance Patterns of the Two MajorTransboundary and emerging diseases · 2025Pooled it
- Review
- Clinical Characteristics and Outcome of Brucella Endocarditis: A Case Series.Infection and drug resistance · 2024Article
- Identifying potential natural inhibitors of Brucella melitensis Methionyl-tRNA synthetase through an in-silico approach.PLoS neglected tropical diseases · 2022Article
- Investigation of antibiotic susceptibilities of Brucella Strains isolated from various clinical samples in eastern Turkey.European journal of medical research · 2021Article
- Antimicrobial susceptibility ofIranian journal of microbiology · 2019Article
- Antimicrobial Resistance inMicrobiology spectrum · 2018Review
- Whole-genome sequencing and antimicrobial resistance in Brucella melitensis from a Norwegian perspective.Scientific reports · 2018Article
- In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Ulanqab of Inner Mongolia, China.BMC infectious diseases · 2018Article
- Antimicrobial susceptibility ofAntimicrobial resistance and infection control · 2017Article
- Species-specific PCR for the Diagnosis and Determination of Antibiotic Susceptibilities ofIranian journal of pathology · 2016Article
- In vitro antimicrobial susceptibility testing of human Brucella melitensis isolates from Qatar between 2014 - 2015.BMC microbiology · 2015Article
- Article
- Identification and in vitro antimicrobial susceptibility of Brucella species isolated from human brucellosis.International journal of microbiology · 2014Article
- Brucellosis in low-income and middle-income countries.Current opinion in infectious diseases · 2013Review
- Identification and determination of antibiotic susceptibilities of Brucella strains isolated from patients in van, Turkey by conventional and molecular methods.International journal of medical sciences · 2013Article
- Brucella spp isolated from respiratory sample and grown in Mycobacterium growth indicator tube (MGIT).Annals of Saudi medicineArticle
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors at 5 institutions in 2 countries.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeBrucellosis is a worldwide zoonotic disease and still constitutes a major public health problem. In the study we claimed to identify Brucella species from clinical samples of patients with active brucellosis from Van region of Eastern Anatolia and to determine in vitro antimicrobial susceptibilities of these strains to commonly used anti-Brucella agents and a possible new alternative tigecycline. MATERIALS AND
methodsA total of 56 Brucella isolates were enrolled the study and the identification of the isolates were based on conventional methods. In vitro activities of antimicrobials were evaluated by the E test method.
resultsAll isolates were identified as B. melitensis. MIC(90) values of doxycycline, streptomycin, rifampin, trimethoprim-sulfamethoxazole and tigecycline were 0.064 mg/L, 1 mg/L, 2 mg/L, 0.125 mg/L and 0.094 mg/L, respectively. Tigecycline had low MIC(50) and MIC(90) values against all B. melitensis strains; the highest MIC observed was 0.25 μg/mL.
conclusionOur data suggest that tigecycline can be a therapeutic alternative option for the treatment of brucellosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.